Prihlásiť sa Zaregistrujte sa zadarmo

Dlh / vlastný kapitál spoločnosti 10x Genomics

Aká je hodnota metriky Dlh / vlastný kapitál spoločnosti 10x Genomics?

Hodnota metriky Dlh / vlastný kapitál spoločnosti 10x Genomics, Inc. je 0.30

Aká je definícia metriky Dlh / vlastný kapitál?



Dlh / vlastný kapitál (Debt to equity ratio) ukazovateľ vyjadruje pomer vlastného kapitálu a cudzích zdrojov na financovanie majetku spoločnosti.

The debt to equity ratio is generally calculated by dividing debt by equity. The D/E ratio is also known as risk, gearing or leverage. The two components are often taken from the firm's balance sheet or statement of financial position (so-called book value), but the ratio may also be calculated using market values for both, if the company's debt and equity are publicly traded, or using a combination of book value for debt and market value for equity financially. Preferred stock can be considered part of debt or equity. Attributing preferred shares to one or the other is partially a subjective decision but will also take into account the specific features of the preferred shares. When used to calculate a company's financial leverage, the debt usually includes only the long-term debt.

Dlh / vlastný kapitál spoločností v sektore Health Care sektor na NASDAQ v porovnaní so spoločnosťou 10x Genomics

Čomu sa venuje spoločnosť 10x Genomics?

10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumables products. Its single cell solutions runs on its chromium instruments, which include single cell gene expression for measuring gene activity on a cell-by-cell basis; single cell immune profiling for measuring the activity of immune cells and their targets; single cell ATAC for measuring epigenetics comprising the physical organization of DNA; and single cell multiome ATAC + gene expression for measuring the genetic activity and epigenetic programming in the same cells across tens of thousands of cells in a single experiment. The company also provides visium spatial gene expression solution for measuring spatial gene expression patterns across a single tissue sample or gene expression and protein co-detection when combined with immunofluorescence. It serves various academic, government, biopharmaceutical, biotechnology, and other institutions. The company was formerly known as 10X Technologies, Inc. and changed its name to 10x Genomics, Inc. in November 2014. 10x Genomics, Inc. was incorporated in 2012 and is headquartered in Pleasanton, California.

Firmy s metrikou dlh / vlastný kapitál podobnou spoločnosti 10x Genomics



  • Hodnota metriky Dlh / vlastný kapitál spoločnosti TREX Co je 0.30
  • Hodnota metriky Dlh / vlastný kapitál spoločnosti Softpower International je 0.30
  • Hodnota metriky Dlh / vlastný kapitál spoločnosti Kitex Garments je 0.30
  • Hodnota metriky Dlh / vlastný kapitál spoločnosti Life360 je 0.30
  • Hodnota metriky Dlh / vlastný kapitál spoločnosti Replimune Inc je 0.30
  • Hodnota metriky Dlh / vlastný kapitál spoločnosti Rexahn Pharmaceuticals je 0.30
  • Hodnota metriky Dlh / vlastný kapitál spoločnosti 10x Genomics je 0.30
  • Hodnota metriky Dlh / vlastný kapitál spoločnosti DroneShield je 0.30
  • Hodnota metriky Dlh / vlastný kapitál spoločnosti Eguarantee je 0.30
  • Hodnota metriky Dlh / vlastný kapitál spoločnosti GCL New je 0.30
  • Hodnota metriky Dlh / vlastný kapitál spoločnosti Goldstone Technologies je 0.30
  • Hodnota metriky Dlh / vlastný kapitál spoločnosti Chinese Estates je 0.30
  • Hodnota metriky Dlh / vlastný kapitál spoločnosti CALBEE je 0.30